A 10-year survival update on early-stage extranodal natural killer/T-cell lymphoma with ‘sandwich’ therapy-Reference-Cited by-同舟云学术

A 10-year survival update on early-stage extranodal natural killer/T-cell lymphoma with ‘sandwich’ therapy

Published:2022-02-28 Issue:5 Volume:61 Page:611-614
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Yang Chunli¹,Zhang Li²,Jiang Ming³,Xie Li³,Zhang Hong³,Liu Weiping⁴,Zhang Wenyan⁴,Zhao Sha⁴,Zou Liqun³

Affiliation:

1. State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China

2. National Cancer Center/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China

3. Department of Oncology, West China Hospital of Sichuan University, Chengdu, China

4. Department of Pathology, West China Hospital of Sichuan University, Chengdu, China

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2022.2044516

Reference11 articles.

1. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer (IARC) 69372 Lyon Cedex 08, France 2017.

2. International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes

3. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1483.

4. Phase 2 trial of “Sandwich”L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma

5. Five‐year analysis from phase 2 trial of “sandwich” chemoradiotherapy in newly diagnosed, stage IE to IIE , nasal type, extranodal natural killer/T‐cell lymphoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-33 aggravates extranodal NK/T cell lymphoma aggressiveness and angiogenesis by activating the Wnt/β-catenin signaling pathway;Molecular and Cellular Biochemistry;2024-03-05

2. Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma;Cancers;2023-02-21

3. Loss of LEF‐1 expression as a diagnostic indicator for extranodal NK/T‐cell lymphoma: An immunohistochemical study of 88 cases;European Journal of Haematology;2022-08-02